AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
+50.19%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$75.2M
AUM Growth
+$75.2M
(+28%)
Cap. Flow
-$382K
Cap. Flow
% of AUM
-0.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
Annexon
ANNX
|
$1.59M |
Top Sells
| 1 |
Assembly Biosciences
ASMB
|
$1.97M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Annexon
ANNX
$226M
| $33.6M | 44.74% | 7,406,024 +350,000 | +5% | +$1.59M |
|
2
Akebia Therapeutics
AKBA
$833M
| $20.1M | 26.74% | 16,205,119 | – | – |
|
3
American Well
AMWL
$111M
| $15.6M | 20.77% | 10,475,717 | – | – |
|
|
WHWK
4
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $3.29M | 4.38% | 1,630,830 | – | – |
|
|
RNTX
5
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $2.53M | 3.37% | 830,466 | – | – |
|
|
6
Assembly Biosciences
ASMB
$190M
| – | – | -2,227,500 | Closed | -$1.97M |
|